Have a look at what’s happening in the world of Abex…
is your business mentioned in our news?
Have a look at what’s happening in the world of Abex… is your business mentioned in our news?
Ascendis Healthcare have been awarded the distribution rights to Tamsulosin tablets under the tradename “PROSTAFLO” in South Africa.read more
Adcock launched the brand “SEREZ” (Quetiapine tablets) onto the SA market during February 2012.read more
Cipla-Medpro launched the brand “QUETOSER” (Quetiapine tablets) in South Africa during April 2012.read more
Ascendis Healthcare have been awarded the distribution rights to Azithromycin 500mg tablets under the tradename “ZEEMIDE” in South Africa.read more
ABEX Pharmaceutica received approval for two separate marketing Authorisations for the molecule donepezil in July.read more
Watson Pharmaceuticals launched the brands “HYTENZA” and “HYTENZA CO” (Losartan 50mg, 100mg tablets and Losartan plus Hydrochlorothiazide 50mg/12,5mg, 100mg/25mg) in South Africa on 26th June 2012.read more
ABEX Pharmaceutica have licensed Activo to market and distribute the brand LESTAVOR under their own label for the South Africa market in January 2014.read more
ABEX successfully contracted to license and supply Watson Pharmaceuticals with their registered brand of atorvastatin tablets under the tradename ASTOR.read more
ABEX Pharmaceutica recently received registration approval for Gabapentin capsules (100mg, 300mg and 400mg) which will shortly be launched under a distribution agreement.read more